Growth Metrics

Ultragenyx Pharmaceutical (RARE) Cash & Equivalents Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -68.22%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 988.88%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 15.64%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.77%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.50%
7 Evaxion A 62.56 Bn 62.54 Bn - 3.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -4.13%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 67.78%
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn 37.80%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 37.80%
Dec 31, 2025 141.95%
Sep 30, 2025 34.45%
Jun 30, 2025 -63.32%
Mar 31, 2025 13.14%
Dec 31, 2024 -18.69%
Sep 30, 2024 107.54%
Jun 30, 2024 371.00%
Mar 31, 2024 30.88%
Dec 31, 2023 60.97%
Sep 30, 2023 -81.47%
Jun 30, 2023 -36.16%
Mar 31, 2023 -44.30%
Dec 31, 2022 -56.78%
Sep 30, 2022 98.27%
Jun 30, 2022 -45.04%
Mar 31, 2022 -59.88%
Dec 31, 2021 -56.89%
Sep 30, 2021 0.03%
Jun 30, 2021 -13.34%
Mar 31, 2021 28.71%
Dec 31, 2020 64.56%
Sep 30, 2020 61.11%
Jun 30, 2020 155.56%
Mar 31, 2020 10.56%
Dec 31, 2019 282.24%
Sep 30, 2019 47.76%
Jun 30, 2019 18.48%
Mar 31, 2019 18.96%
Dec 31, 2018 12.88%
Sep 30, 2018 37.33%
Jun 30, 2018 22.15%
Mar 31, 2018 42.15%
Dec 31, 2017 -37.63%
Sep 30, 2017 -57.54%
Jun 30, 2017 64.80%
Mar 31, 2017 125.40%
Dec 31, 2016 72.19%
Sep 30, 2016 -14.64%
Jun 30, 2016 5.19%
Mar 31, 2016 -60.25%
Dec 31, 2015 284.68%
Sep 30, 2015 212.22%
Jun 30, 2015 199.97%
Mar 31, 2015 221.10%
Dec 31, 2014 227.51%
Sep 30, 2014 782.58%
Jun 30, 2014 29.21%
Mar 31, 2014 -14.43%